BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28829664)

  • 1. Risk Factors for Post-Transplant Death in Donation after Circulatory Death Liver Transplantation.
    Liu S; Miao J; Shi X; Wu Y; Jiang C; Zhu X; Wu X; Ding Y; Xu Q
    J Invest Surg; 2018 Oct; 31(5):393-401. PubMed ID: 28829664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MELD score measured day 10 after orthotopic liver transplantation predicts death and re-transplantation within the first year.
    Rostved AA; Lundgren JD; Hillingsø J; Peters L; Mocroft A; Rasmussen A
    Scand J Gastroenterol; 2016 Nov; 51(11):1360-6. PubMed ID: 27319374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver Transplantation for Hepatic Epithelioid Hemangioendothelioma Is Facilitated by Exception Points With Acceptable Long-term Outcomes.
    Brahmbhatt M; Prenner S; Bittermann T
    Transplantation; 2020 Jun; 104(6):1187-1192. PubMed ID: 31577674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter study of 30 days complications after deceased donor liver transplantation in the model for end-stage liver disease score era.
    Parikh A; Washburn KW; Matsuoka L; Pandit U; Kim JE; Almeda J; Mora-Esteves C; Halff G; Genyk Y; Holland B; Wilson DJ; Sher L; Koneru B
    Liver Transpl; 2015 Sep; 21(9):1160-8. PubMed ID: 25991395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of Hepatitis B Virus Infection After Living-Donor Liver Transplant: A Single-center Experience Over 20 Years.
    Nafady-Hego H; Elgendy H; Nafady A; Uemoto S
    Exp Clin Transplant; 2016 Apr; 14(2):207-14. PubMed ID: 26867537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors and impacts of hospital readmissions following liver transplantation.
    Yataco M; Cowell A; David W; Keaveny AP; Taner CB; Patel T
    Ann Hepatol; 2016; 15(3):356-62. PubMed ID: 27049489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does Donation After Cardiac Death Utilization Adversely Affect Hepatocellular Cancer Survival?
    Khorsandi SE; Yip VS; Cortes M; Jassem W; Quaglia A; O'Grady J; Heneghan M; Aluvihare V; Agarwal K; Menon K; Vilca-Melendez H; Prachalias A; Srinivasan P; Suddle A; Rela M; Heaton N
    Transplantation; 2016 Sep; 100(9):1916-24. PubMed ID: 26982954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of pretransplant albumin-bilirubin score in predicting outcomes after liver transplantation.
    Ma T; Li QS; Wang Y; Wang B; Wu Z; Lv Y; Wu RQ
    World J Gastroenterol; 2019 Apr; 25(15):1879-1889. PubMed ID: 31057301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for abdominal bleeding after living-donor liver transplant.
    Li C; Wen TF; Yan LN; Li B
    Exp Clin Transplant; 2014 Oct; 12(5):424-8. PubMed ID: 24568675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Outcomes and Risk Factors After Adult Living Donor Liver Transplantation.
    Imai D; Yoshizumi T; Sakata K; Ikegami T; Itoh S; Harada N; Motomura T; Toshima T; Mano Y; Soejima Y; Maehara Y
    Transplantation; 2018 Sep; 102(9):e382-e391. PubMed ID: 29912047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone mineral density predicts posttransplant survival among hepatocellular carcinoma liver transplant recipients.
    Sharma P; Parikh ND; Yu J; Barman P; Derstine BA; Sonnenday CJ; Wang SC; Su GL
    Liver Transpl; 2016 Aug; 22(8):1092-8. PubMed ID: 27064263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
    Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
    J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor characteristics and risk of hepatocellular carcinoma recurrence after liver transplantation.
    Orci LA; Berney T; Majno PE; Lacotte S; Oldani G; Morel P; Mentha G; Toso C
    Br J Surg; 2015 Sep; 102(10):1250-7. PubMed ID: 26098966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Italian Score for Organ Allocation System on Deceased Donor Liver Transplantation: A Monocentric Competing Risk Time-to-Event Analysis.
    Khouzam S; Pagano D; Barbàra M; Cintorino D; Li Petri S; di Francesco F; Ricotta C; Bonsignore P; Seidita A; Calamia S; Canzonieri M; Tropea A; Gruttadauria S
    Transplant Proc; 2019 Nov; 51(9):2860-2864. PubMed ID: 31711575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes utilizing imported liver grafts for recipients with hepatocellular carcinoma.
    Battula N; Reichman TW; Amiri Y; Carmody IC; Galliano G; Seal J; Bugeaud E; Bohorquez H; Bruce D; Cohen A; Loss GE
    Liver Transpl; 2017 Mar; 23(3):299-304. PubMed ID: 28026108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of living and deceased donor liver transplantation as a treatment for hepatocellular carcinoma.
    Ninomiya M; Shirabe K; Facciuto ME; Schwartz ME; Florman SS; Yoshizumi T; Harimoto N; Ikegami T; Uchiyama H; Maehara Y
    J Am Coll Surg; 2015 Mar; 220(3):297-304.e3. PubMed ID: 25617912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting survival after liver transplantation using up-to-seven criteria in patients with hepatocellular carcinoma.
    de Ataide EC; Garcia M; Mattosinho TJ; Almeida JR; Escanhoela CA; Boin IF
    Transplant Proc; 2012 Oct; 44(8):2438-40. PubMed ID: 23026614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.
    Sasaki K; Firl DJ; Hashimoto K; Fujiki M; Diago-Uso T; Quintini C; Eghtesad B; Fung JJ; Aucejo FN; Miller CM
    Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):595-603. PubMed ID: 28546007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver transplant for hepatocellular carcinoma: experience in a Saudi population.
    Allam N; Khalaf H; Fagih M; Al-Sebayel M
    Exp Clin Transplant; 2008 Mar; 6(1):14-24. PubMed ID: 18405240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
    Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.